1-4 of 4
Authors: David P. Dearnaley
Sort by
Journal Article
Radiogenomics Consortium Genome-Wide Association Study Meta-Analysis of Late Toxicity After Prostate Cancer Radiotherapy Open Access
Sarah L Kerns and others
JNCI: Journal of the National Cancer Institute, Volume 112, Issue 2, February 2020, Pages 179–190, https://doi.org/10.1093/jnci/djz075
Published: 16 May 2019
Journal Article
Multiple Loci With Different Cancer Specificities Within the 8q24 Gene Desert
Get access
Maya Ghoussaini and others
JNCI: Journal of the National Cancer Institute, Volume 100, Issue 13, 2 July 2008, Pages 962–966, https://doi.org/10.1093/jnci/djn190
Published: 02 July 2008
Journal Article
Oral Sodium Clodronate for Nonmetastatic Prostate Cancer—Results of a Randomized Double-Blind Placebo-Controlled Trial: Medical Research Council PR04 (ISRCTN61384873)
Get access
Malcolm D. Mason and others
JNCI: Journal of the National Cancer Institute, Volume 99, Issue 10, 16 May 2007, Pages 765–776, https://doi.org/10.1093/jnci/djk178
Published: 16 May 2007
Journal Article
A Double-Blind, Placebo-Controlled, Randomized Trial of Oral Sodium Clodronate for Metastatic Prostate Cancer (MRC PR05 Trial)
Get access
David P. Dearnaley and others
JNCI: Journal of the National Cancer Institute, Volume 95, Issue 17, 3 September 2003, Pages 1300–1311, https://doi.org/10.1093/jnci/djg038
Published: 03 September 2003
Advertisement
Advertisement